Literature DB >> 27177984

Clinical and genetic analysis of two Chinese infants with Mabry syndrome.

Jiao Xue1, Hui Li1, Yuehua Zhang1, Zhixian Yang2.   

Abstract

OBJECTIVE: Hyperphosphatasia mental retardation syndrome (Mabry syndrome) is an autosomal recessive disorder. We aim to analyze two Chinese patients diagnosed as Mabry syndrome.
METHODS: The clinical manifestations, diagnosis and treatment were observed in two patients. Genetic analysis including PIGV and PIGO was examined.
RESULTS: Two patients were diagnosed as Mabry syndrome clinically and genetically. Developmental delay, hyperphosphatasia and seizures were presented in both of them. Typical facial dysmorphism and hypoplastic terminal phalanges were only found in one. Some novel presentations including congenital laryngeal cartilage softening, inguinal hernia, broken palmprint, optic atrophy and skeleton dysplasia such as carpal age delay and metaphysis anomalies were observed in two patients. Molecular genetic analysis revealed compound heterozygous mutations of PIGV or PIGO in our patients, including c.615C>G (p.Asn205Lys) and c.854A>G (p.Tyr285Cys) of PIGV in patient 1, and c.458T>C (p.Phe153Ser) and c.1355_1356del (p.Ala452Glyfs*52) of PIGO in patient 2. Additionally, a heterozygous c.2926G>A (Asp976Asn) of PCDH19 was identified in patient with PIGV mutations, the causative gene of Epilepsy and mental retardation limited to females (EFMR).
CONCLUSION: To our best knowledge, this is the first time to report Chinese patients diagnosed as Mabry syndrome. For the PCDH19 mutation in our patient carrying PIGV mutations, due to lacking characteristics of EFMR and the ambiguity results in pathogenicity analysis, we were not sure how much pathogenic role PCDH19 mutation shared with PIGV mutations in this disease. The novel mutations of PIGV and PIGO, and novel clinical manifestations reported here might expand the genotype and phenotype spectrum of Mabry syndrome.
Copyright © 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive disability; Hyperphosphatasia; PIGO gene; PIGV gene; Seizures

Mesh:

Substances:

Year:  2016        PMID: 27177984     DOI: 10.1016/j.braindev.2016.04.008

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  11 in total

1.  Mutations in PIGS, Encoding a GPI Transamidase, Cause a Neurological Syndrome Ranging from Fetal Akinesia to Epileptic Encephalopathy.

Authors:  Thi Tuyet Mai Nguyen; Yoshiko Murakami; Kristen M Wigby; Nissan V Baratang; Justine Rousseau; Anik St-Denis; Jill A Rosenfeld; Stephanie C Laniewski; Julie Jones; Alejandro D Iglesias; Marilyn C Jones; Diane Masser-Frye; Angela E Scheuerle; Denise L Perry; Ryan J Taft; Françoise Le Deist; Miles Thompson; Taroh Kinoshita; Philippe M Campeau
Journal:  Am J Hum Genet       Date:  2018-09-27       Impact factor: 11.025

2.  Novel phenotypes of pyridox(am)ine-5'-phosphate oxidase deficiency and high prevalence of c.445_448del mutation in Chinese patients.

Authors:  Jiao Xue; Xingzhi Chang; Yuehua Zhang; Zhixian Yang
Journal:  Metab Brain Dis       Date:  2017-03-27       Impact factor: 3.584

3.  A homozygous PIGO mutation associated with severe infantile epileptic encephalopathy and corpus callosum hypoplasia, but normal alkaline phosphatase levels.

Authors:  Yoav Zehavi; Anja von Renesse; Etty Daniel-Spiegel; Yonatan Sapir; Luci Zalman; Ilana Chervinsky; Markus Schuelke; Rachel Straussberg; Ronen Spiegel
Journal:  Metab Brain Dis       Date:  2017-09-13       Impact factor: 3.584

4.  Characterization of glycosylphosphatidylinositol biosynthesis defects by clinical features, flow cytometry, and automated image analysis.

Authors:  Alexej Knaus; Jean Tori Pantel; Manuela Pendziwiat; Nurulhuda Hajjir; Max Zhao; Tzung-Chien Hsieh; Max Schubach; Yaron Gurovich; Nicole Fleischer; Marten Jäger; Sebastian Köhler; Hiltrud Muhle; Christian Korff; Rikke S Møller; Allan Bayat; Patrick Calvas; Nicolas Chassaing; Hannah Warren; Steven Skinner; Raymond Louie; Christina Evers; Marc Bohn; Hans-Jürgen Christen; Myrthe van den Born; Ewa Obersztyn; Agnieszka Charzewska; Milda Endziniene; Fanny Kortüm; Natasha Brown; Peter N Robinson; Helenius J Schelhaas; Yvonne Weber; Ingo Helbig; Stefan Mundlos; Denise Horn; Peter M Krawitz
Journal:  Genome Med       Date:  2018-01-09       Impact factor: 11.117

Review 5.  PIGO deficiency: palmoplantar keratoderma and novel mutations.

Authors:  Marie-Anne Morren; Jaak Jaeken; Gepke Visser; Isabelle Salles; Chris Van Geet; Ilenia Simeoni; Ernest Turro; Kathleen Freson
Journal:  Orphanet J Rare Dis       Date:  2017-05-25       Impact factor: 4.123

6.  A novel PGAP3 mutation in a Croatian boy with brachytelephalangy and a thin corpus callosum.

Authors:  Tomohiro Sakaguchi; Tamara Žigman; Danijela Petković Ramadža; Lana Omerza; Silvija Pušeljić; Zrinka Ereš Hrvaćanin; Noriko Miyake; Naomichi Matsumoto; Ivo Barić
Journal:  Hum Genome Var       Date:  2018-03-08

7.  Hyperphosphatasia with mental retardation syndrome, expanded phenotype of PIGL related disorders.

Authors:  Ruqaiah Altassan; Stephanie Fox; Chantal Poulin; Daniela Buhas
Journal:  Mol Genet Metab Rep       Date:  2018-02-06

8.  A likely pathogenic variant putatively affecting splicing of PIGA identified in a multiple congenital anomalies hypotonia-seizures syndrome 2 (MCAHS2) family pedigree via whole-exome sequencing.

Authors:  Junli Yang; Qiong Wang; Qingcui Zhuo; Huiling Tian; Wen Li; Fang Luo; Jinghui Zhang; Dan Bi; Jing Peng; Dong Zhou; Huawei Xin
Journal:  Mol Genet Genomic Med       Date:  2018-07-04       Impact factor: 2.183

Review 9.  The Glycosylphosphatidylinositol biosynthesis pathway in human diseases.

Authors:  Tenghui Wu; Fei Yin; Shiqi Guang; Fang He; Li Yang; Jing Peng
Journal:  Orphanet J Rare Dis       Date:  2020-05-28       Impact factor: 4.123

10.  Mosaicism and incomplete penetrance of PCDH19 mutations.

Authors:  Aijie Liu; Xiaoxu Yang; Xiaoling Yang; Qixi Wu; Jing Zhang; Dan Sun; Zhixian Yang; Yuwu Jiang; Xiru Wu; Liping Wei; Yuehua Zhang
Journal:  J Med Genet       Date:  2018-10-04       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.